Voriconazole and caspofungin – novel drugs in treatment of systemic fungal infections

Anna Mleczko

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2004
vol. 21

Send email

Copy url:

abstract:

Voriconazole and caspofungin – novel drugs in treatment of systemic fungal infections

Anna Mleczko

Online publish date: 2004/10/27

View full text Get citation

Voriconazole and caspofungin – novel drugs in treatment of systemic fungal infections.
In this study voriconazole and caspofungin mechanism of action has been shown and efficacy and safety of both drugs have been compared with liposomal and conventional amphotericin B. Indications and contraindications for prophylaxis, empirical antifungal therapy, pre- emptive therapy and invasive treatment of fungal infections were described.

keywords:

Voriconazole and caspofungin – novel drugs in treatment of systemic fungal infections

Anna Mleczko

fever, persistent fever, neutropenia, randomised studies, fungaemia, zygomycosis, pre-emptive therapy